Annual SG&A
$23.30 M
-$9.84 M-29.69%
30 June 2024
Summary:
MEI Pharma annual selling, general & administrative expenses is currently $23.30 million, with the most recent change of -$9.84 million (-29.69%) on 30 June 2024. During the last 3 years, it has fallen by -$1.12 million (-4.58%). MEIP annual SG&A is now -29.69% below its all-time high of $33.13 million, reached on 30 June 2023.MEIP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.19 M
+$1.05 M+25.43%
30 September 2024
Summary:
MEI Pharma quarterly selling, general & administrative expenses is currently $5.19 million, with the most recent change of +$1.05 million (+25.43%) on 30 September 2024. Over the past year, it has dropped by -$1.34 million (-20.55%). MEIP quarterly SG&A is now -47.94% below its all-time high of $9.97 million, reached on 30 June 2023.MEIP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.51 B
-$46.60 M-3.17%
30 September 2024
Summary:
MEI Pharma TTM selling, general & administrative expenses is currently -$1.51 billion, with the most recent change of -$46.60 million (-3.17%) on 30 September 2024. Over the past year, it has dropped by -$1.55 billion (-4808.45%). MEIP TTM SG&A is now -47902.03% below its all-time high of $33.13 million, reached on 30 June 2023.MEIP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.7% | -20.6% | -4808.4% |
| 3 y3 years | -4.6% | -34.4% | -5836.7% |
| 5 y5 years | +59.6% | +25.6% | -9984.8% |
MEIP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.7% | at low | -47.9% | +25.4% | -19.1% | +3.7% |
| 5 y | 5 years | -29.7% | +59.6% | -47.9% | +34.3% | -65.3% | +3.7% |
| alltime | all time | -29.7% | +3461.9% | -47.9% | +847.7% | <-9999.0% | +3.7% |
MEI Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.19 M(+25.4%) | $21.95 M(-5.8%) |
| June 2024 | $23.30 M(-29.7%) | $4.14 M(-10.2%) | $23.30 M(-20.0%) |
| Mar 2024 | - | $4.61 M(-42.5%) | $29.13 M(-8.1%) |
| Dec 2023 | - | $8.02 M(+22.8%) | $31.70 M(-1.5%) |
| Sept 2023 | - | $6.53 M(-34.5%) | $32.17 M(-2.9%) |
| June 2023 | $33.13 M(+8.5%) | $9.97 M(+38.8%) | $33.13 M(+14.5%) |
| Mar 2023 | - | $7.18 M(-15.5%) | $28.93 M(-5.7%) |
| Dec 2022 | - | $8.50 M(+13.5%) | $30.69 M(+1.9%) |
| Sept 2022 | - | $7.49 M(+29.7%) | $30.12 M(-1.4%) |
| June 2022 | $30.54 M(+25.1%) | $5.77 M(-35.4%) | $30.54 M(-2.7%) |
| Mar 2022 | - | $8.93 M(+12.7%) | $31.40 M(+9.5%) |
| Dec 2021 | - | $7.93 M(+0.2%) | $28.68 M(+8.6%) |
| Sept 2021 | - | $7.91 M(+19.2%) | $26.41 M(+8.2%) |
| June 2021 | $24.41 M(+46.0%) | $6.63 M(+6.7%) | $24.41 M(+9.4%) |
| Mar 2021 | - | $6.21 M(+10.0%) | $22.31 M(+11.8%) |
| Dec 2020 | - | $5.65 M(-4.5%) | $19.96 M(+7.9%) |
| Sept 2020 | - | $5.92 M(+30.6%) | $18.50 M(+10.7%) |
| June 2020 | $16.72 M(+14.5%) | $4.53 M(+17.2%) | $16.72 M(+4.9%) |
| Mar 2020 | - | $3.86 M(-7.9%) | $15.93 M(+1.5%) |
| Dec 2019 | - | $4.20 M(+1.6%) | $15.70 M(+2.4%) |
| Sept 2019 | - | $4.13 M(+10.3%) | $15.33 M(+5.0%) |
| June 2019 | $14.60 M(+49.1%) | $3.74 M(+3.1%) | $14.60 M(+9.7%) |
| Mar 2019 | - | $3.63 M(-5.0%) | $13.31 M(+9.4%) |
| Dec 2018 | - | $3.82 M(+12.3%) | $12.16 M(+13.7%) |
| Sept 2018 | - | $3.40 M(+38.5%) | $10.70 M(+9.3%) |
| June 2018 | $9.79 M(+13.4%) | $2.46 M(-1.2%) | $9.79 M(+6.9%) |
| Mar 2018 | - | $2.49 M(+5.4%) | $9.16 M(+3.8%) |
| Dec 2017 | - | $2.36 M(-5.2%) | $8.82 M(+4.6%) |
| Sept 2017 | - | $2.49 M(+36.3%) | $8.44 M(-2.2%) |
| June 2017 | $8.63 M(+13.5%) | $1.83 M(-15.1%) | $8.63 M(-0.1%) |
| Mar 2017 | - | $2.15 M(+9.2%) | $8.64 M(+1.9%) |
| Dec 2016 | - | $1.97 M(-26.5%) | $8.48 M(+0.3%) |
| Sept 2016 | - | $2.68 M(+46.0%) | $8.45 M(+11.2%) |
| June 2016 | $7.60 M(-15.1%) | $1.84 M(-7.7%) | $7.60 M(-1.0%) |
| Mar 2016 | - | $1.99 M(+2.3%) | $7.67 M(-2.5%) |
| Dec 2015 | - | $1.95 M(+6.3%) | $7.87 M(-5.6%) |
| Sept 2015 | - | $1.83 M(-4.1%) | $8.34 M(-6.8%) |
| June 2015 | $8.95 M(+38.8%) | $1.91 M(-12.6%) | $8.95 M(+15.7%) |
| Mar 2015 | - | $2.19 M(-9.5%) | $7.74 M(+2.6%) |
| Dec 2014 | - | $2.42 M(-1.0%) | $7.54 M(+6.6%) |
| Sept 2014 | - | $2.44 M(+249.9%) | $7.08 M(+9.7%) |
| June 2014 | $6.45 M | $697.00 K(-65.0%) | $6.45 M(+4.7%) |
| Mar 2014 | - | $1.99 M(+2.2%) | $6.16 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | - | $1.95 M(+7.6%) | $5.39 M(+10.9%) |
| Sept 2013 | - | $1.81 M(+345.0%) | $4.86 M(+22.6%) |
| June 2013 | $3.96 M(+45.0%) | $407.00 K(-66.8%) | $3.96 M(+7.3%) |
| Mar 2013 | - | $1.23 M(-13.6%) | $3.69 M(+12.6%) |
| Dec 2012 | - | $1.42 M(+55.1%) | $3.28 M(+18.9%) |
| Sept 2012 | - | $914.00 K(+562.3%) | $2.76 M(+0.9%) |
| June 2012 | $2.73 M(-36.9%) | $138.00 K(-83.0%) | $2.73 M(-19.6%) |
| Mar 2012 | - | $811.00 K(-9.5%) | $3.40 M(-6.1%) |
| Dec 2011 | - | $896.00 K(+0.8%) | $3.62 M(-11.2%) |
| Sept 2011 | - | $889.00 K(+10.3%) | $4.08 M(-5.9%) |
| June 2011 | $4.34 M(+9.8%) | $806.00 K(-22.0%) | $4.34 M(-1.7%) |
| Mar 2011 | - | $1.03 M(-23.6%) | $4.41 M(+8.9%) |
| Dec 2010 | - | $1.35 M(+18.1%) | $4.05 M(+28.1%) |
| Sept 2010 | - | $1.15 M(+30.3%) | $3.16 M(-19.9%) |
| June 2010 | $3.95 M(+8.8%) | $879.00 K(+30.6%) | $3.95 M(-31.1%) |
| Mar 2010 | - | $673.00 K(+44.7%) | $5.73 M(+5.2%) |
| Dec 2009 | - | $465.00 K(-75.9%) | $5.45 M(+2.9%) |
| Sept 2009 | - | $1.93 M(-27.5%) | $5.29 M(+45.8%) |
| June 2009 | $3.63 M(-3.4%) | $2.66 M(+586.3%) | $3.63 M(+105.5%) |
| Mar 2009 | - | $388.00 K(+25.2%) | $1.77 M(-41.1%) |
| Dec 2008 | - | $310.00 K(+15.2%) | $3.00 M(-10.5%) |
| Sept 2008 | - | $269.00 K(-66.3%) | $3.35 M(-10.9%) |
| June 2008 | $3.76 M(-56.8%) | $799.00 K(-50.7%) | $3.76 M(+5.1%) |
| Mar 2008 | - | $1.62 M(+145.5%) | $3.57 M(+48.9%) |
| Dec 2007 | - | $660.00 K(-2.5%) | $2.40 M(+4.7%) |
| Sept 2007 | - | $677.00 K(+9.9%) | $2.29 M(-73.7%) |
| June 2007 | $8.70 M(+97.6%) | $616.00 K(+37.8%) | $8.70 M(+17.7%) |
| Mar 2007 | - | $447.00 K(-19.0%) | $7.39 M(-20.2%) |
| Dec 2006 | - | $552.00 K(-92.2%) | $9.27 M(-8.7%) |
| Sept 2006 | - | $7.09 M(-1121.3%) | $10.15 M(+130.5%) |
| June 2006 | $4.40 M(-1.0%) | -$694.00 K(-129.9%) | $4.40 M(-32.0%) |
| Mar 2006 | - | $2.32 M(+61.2%) | $6.48 M(+18.3%) |
| Dec 2005 | - | $1.44 M(+7.5%) | $5.47 M(+11.0%) |
| Sept 2005 | - | $1.34 M(-2.9%) | $4.93 M(+10.8%) |
| June 2005 | $4.45 M(-29.9%) | $1.38 M(+4.7%) | $4.45 M(+19.1%) |
| Mar 2005 | - | $1.32 M(+47.0%) | $3.73 M(+12.4%) |
| Dec 2004 | - | $896.00 K(+4.4%) | $3.32 M(-51.5%) |
| Sept 2004 | - | $858.00 K(+29.2%) | $6.85 M(+8.0%) |
| June 2004 | $6.35 M(+870.9%) | $664.00 K(-26.6%) | $6.35 M(+7.7%) |
| Mar 2004 | - | $905.00 K(-79.5%) | $5.89 M(+14.9%) |
| Dec 2003 | - | $4.42 M(+1153.3%) | $5.13 M(+631.1%) |
| Sept 2003 | - | $353.00 K(+69.7%) | $701.00 K(+101.4%) |
| June 2003 | $654.00 K | $208.00 K(+48.6%) | $348.00 K(+148.6%) |
| Mar 2003 | - | $140.00 K | $140.00 K |
FAQ
- What is MEI Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for MEI Pharma?
- What is MEI Pharma annual SG&A year-on-year change?
- What is MEI Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for MEI Pharma?
- What is MEI Pharma quarterly SG&A year-on-year change?
- What is MEI Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for MEI Pharma?
- What is MEI Pharma TTM SG&A year-on-year change?
What is MEI Pharma annual selling, general & administrative expenses?
The current annual SG&A of MEIP is $23.30 M
What is the all time high annual SG&A for MEI Pharma?
MEI Pharma all-time high annual selling, general & administrative expenses is $33.13 M
What is MEI Pharma annual SG&A year-on-year change?
Over the past year, MEIP annual selling, general & administrative expenses has changed by -$9.84 M (-29.69%)
What is MEI Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of MEIP is $5.19 M
What is the all time high quarterly SG&A for MEI Pharma?
MEI Pharma all-time high quarterly selling, general & administrative expenses is $9.97 M
What is MEI Pharma quarterly SG&A year-on-year change?
Over the past year, MEIP quarterly selling, general & administrative expenses has changed by -$1.34 M (-20.55%)
What is MEI Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of MEIP is -$1.51 B
What is the all time high TTM SG&A for MEI Pharma?
MEI Pharma all-time high TTM selling, general & administrative expenses is $33.13 M
What is MEI Pharma TTM SG&A year-on-year change?
Over the past year, MEIP TTM selling, general & administrative expenses has changed by -$1.55 B (-4808.45%)